This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nmd Pharma A/s. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael John Mckenzie: Innovator in Chloride Channel Inhibitors
Introduction
Michael John Mckenzie is a notable inventor based in Leicester, GB. He has made significant contributions to the field of chemistry, particularly in the development of chloride channel inhibitors. His work is characterized by a focus on improving chemical processes, which has implications for various therapeutic applications.
Latest Patents
Mckenzie holds a patent for a "Process for the preparation of CIC-1 chloride channel inhibitors." This patent relates to an improved chemical process for making compounds that serve as CIC-1 chloride channel inhibitors. His innovative approach enhances the efficiency and effectiveness of these compounds, which are crucial in medical research and treatment.
Career Highlights
Throughout his career, Mckenzie has demonstrated a commitment to advancing scientific knowledge and practical applications in his field. His work at NMD Pharma A/S has positioned him as a key player in the pharmaceutical industry, where he continues to explore new avenues for innovation.
Collaborations
Mckenzie collaborates with Nicholas Kelly, contributing to a dynamic research environment that fosters creativity and innovation. Their partnership exemplifies the importance of teamwork in achieving groundbreaking results in scientific research.
Conclusion
Michael John Mckenzie is a distinguished inventor whose work in chloride channel inhibitors showcases his dedication to improving chemical processes. His contributions to the field are invaluable, and his ongoing research promises to yield further advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile